Adjuvant chemotherapy after surgery for pancreatic ductal adenocarcinoma: retrospective real-life data

BACKGROUND: The recommendation for postoperative chemotherapy in pancreatic ductal adenocarcinoma (PDAC) is based on prospective randomized trials. However, patients included in clinical trials do not often reflect the overall patient population treated in clinical practice. MATERIALS AND METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Chikhladze, Sophia, Lederer, Ann-Kathrin, Kousoulas, Lampros, Reinmuth, Marilena, Sick, Olivia, Fichtner-Feigl, Stefan, Wittel, Uwe A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842534/
https://www.ncbi.nlm.nih.gov/pubmed/31706323
http://dx.doi.org/10.1186/s12957-019-1732-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842534/
https://www.ncbi.nlm.nih.gov/pubmed/31706323
http://dx.doi.org/10.1186/s12957-019-1732-3

Ejemplares similares